BACKGROUND: Blood lipoprotein(a) Lp(a) concentrations are an important risk factor for atherosclerosis. The basis for this atherogenic property of Lp(a) and the factors that in¯uence its cross-population levels, however, remain poorly understood. OBJECTIVES: To investigate the relationship between serum Lp(a) and metabolic and anthropometric parameters in a healthy Kuwaiti population. DESIGN: Cross-sectional study. SUBJECTS: 177 (72 male, 105 female) randomly recruited healthy Kuwait Arabs aged 17 ± 60 y MEASUREMENTS: Metabolic parameters in serum: Lp(a), apo(a) phenotypes, lipids and lipoproteins, glucose and urate. Anthropometric parameters: body mass index (BMI) and waist:hip-ratio (WHR). RESULTS: The distribution of Lp(a) concentrations was positively skewed (median 153 mgal, range 0 ± 1086). Women had higher concentrations ± (194, 0 ± 1086) than men (117, 0 ± 779), P 0.069. Lp(a) and insulin concentrations were signi®cantly higher when the men and women were obese. In all subjects, there were signi®cant correlations between Lp(a) and BMI (r 0.23), total cholesterol (TC) (r 0. 
Introduction
Several studies have indicated that elevated lipoprotein(a) Lp(a) concentrations are a strong independent risk factor for premature ischaemic heart disease, 1, 2 cerebrovascular and peripheral vascular disease, 3 and early occlusion of coronary artery bypass grafts and femoropopliteal vein grafts. 4 Genetic factors are the principal determinants of plasma Lp(a) concentrations 5, 6 via differences in apolipoprotein(a) polymorphisms between individuals and races. Other factors such as diet, exercise, body mass, gender 7 and probably insulin levels 8 have, however, been shown to be important determinants of Lp(a) concentrations as well; although probably not quantitatively as important as the genetic determinant. Nonetheless, these non-genetic parameters could be subject to therapeutic intervention in attempts to modify Lp(a) concentrations. 9 Suggested mechanisms for the effects of Lp(a) in modulating vascular disease risk include: (1) anti®brinolytic and prothrombotic effects based on the structural similarity between Lp(a) and plasminogen 10, 11 and the described in¯uence of Lp(a) in regulating the endothelial cell synthesis of tissue plasminogen activator inhibitor PAI-1;
12 (2) signi®-cant uptake of Lp(a) with low-density lipoprotein (LDL) by the LDL native and scavenger receptorsÐ indeed, both lipoproteins co-determine atherosclerotic disease risk. However, these different mechanisms remain controversial 13 and do not always satisfactorily account for the striking atherogenicity of Lp(a).
The Arabian Gulf population, including Kuwaitis, have, in the last decade, witnessed dramatic increases in coronary heart disease (CHD) prevalence due mainly to increasing wealth, Westernization and urbanization. We have been studying cardiovascular disease risk factors in this population 14, 15 and here extend our observations to include the likely determinants of Lp(a) concentrations in a healthy, ambulant Kuwaiti population. Speci®cally, we aimed to investigate: (1) the concentrations and distribution of serum Lp(a) in the population (2) the pattern of apo(a) polymorphism in the study subjects as an index of genetic determination of serum Lp(a); (3) the association between serum Lp(a) and other CHD risk factors ± biochemical (lipids, lipoproteins, urate, glucose, insulin) and anthropometricademographic (body mass, blood pressure, age) ± the putative non-genetic determinants of serum Lp(a).
Subjects and methods
Subjects 177 (72 male, 105 female) healthy, ambulant nonhypertensive, nondiabetic Kuwaiti subjects were recruited randomly from the general Kuwaiti adult population. Kuwait is a city state with a relatively small Kuwaiti adult population (about 300 000) distributed in ®ve governorates located typically within 20 ± 40 km of each other. It was, therefore, relatively easy to get volunteers from all the representative areas of Kuwait. Individual families were contacted either directly by female ®eld staff or by telephone. All who initially volunteered were then interviewed. Strati®ed sampling was then done to choose randomly one volunteerafamily and one familyastreet with emphasis on equal proportions of males and females and as equal as possible representation of the ®ve governorates in the city state. The task was simpli®ed by the relatively small geographical area of the state of Kuwait and also the fact that our teaching hospital and medical school is the only one in the country, providing a country-wide service with which all the recruited subjects were familiar.
The recruited subjects were aged 17 ± 60 y and apparently healthy, normolipidaemic (fasting plasma cholesterol`6.0 mmolal and triglycerides`2.0 mmolal), with normal renal, liver and thyroid function and blood glucose values and normotensive (resting blood pressure (BP)`160a95 mmHg). Patients with chronic systemic illness, diabetes, hypertension and CHD (a total of 32) were excluded from the study.
These volunteers were recruited after informed voluntary consent and interviewed according to a standard pro-forma for age, sex, history of hypertension, diabetes, CHD and thyroid disease, cigarette smoking and medications. Anthropometric indices (weight (kg), height (m), waist and hip circumferences (cm)) were then taken using standard techniques by the same trained observer. The body mass index (BMI) and waist:hip ratio (WHR) for each subject were thereafter calculated. A supine BP estimation was also taken using a sphygmomanometer with an appropriate cuff size. The studies were approved by the local Research Ethics Committee.
Laboratory analysis
Venous samples were collected from each of the subjects in the morning (0800 ± 0900 h) after a 12 ± 14 h overnight fast and analysed for serum lipids and lipoproteins (total cholesterol (TC), triglycerides (TG), high-density lipoprotein (HDL)), uric acid, Lp(a), apo A-1, apo B, insulin and glucose. Serum was extracted after separation of the blood samples in a refrigerated centrifuge (1,800 g, 25 min) within 1 h of specimen collection. Samples not analysed immediately were stored frozen at 7 80 C until analysis always within 3 months of collection. The measurements of TC, TG, HDL, uric acid and glucose were performed in the Clinical Biochemistry Laboratory of the Faculty of Medicine Department of Pathology Building using an Autoanalyser (Hitachi 911, Boehringer Mannheim, Germany) with dedicated reagents obtained from Boehringer Mannheim, Germany. LDL concentrations were subsequently calculated using the Friedewald's formula, for all individuals with TG values`4.5 mmolal. 16 Apo A-1 and B were also measured by an automated immunoturbidimetric method on an Hitachi 911 Autoanalyser (Boehringer Mannheim, Germany) using Tina-quant Apolipoprotein A-1 and B kits and calibrators supplied by Boehringer Mannheim. Intra-and inter-assay coef®-cients of variation (CVs) observed for both apo A-1 and apo B were`2.5%. Lp(a) was determined by ELISA using kits (TintElize Lp(a)) and controls supplied by Biopool, Umea, Sweden; our intra-and inter-assay CV's for this method were respectively 2.0% and 2.3%. Serum insulin concentrations were measured by ELISA using mouse monoclonal antibodies in speci®c kit form (DAKO Diagnostics, Cambridgeshire, UK) ± this assay method is unin¯uenced by hyperlipidaemia and shows no appreciable crossreactivity with pro-insulin and proinsulin split products. Intra-and inter-assay CV's by this method were respectively 7.5% and 8.8%, within the range stipulated by the kit manufacturers.
Apo (a) isoforms were separated using a high resolution SDSaagarose gel electrophoresis as previously reported. 17 ± 19 Modi®cations to these original protocols are similar to the methods described in the article by Min et al. 20 After electrophoresis, the separated proteins were transferred to a nitrocellulose membrane and identi®ed by immunoblotting. Immunodetection was performed with a Lp(a) phenotyping kit (IMMUNO AG, Vienna, Austria) which contained anti human sheep Lp(a), anti sheep IgG (Fc)-alkaline phosphatase-conjugate (rabbit), Lp(a) specimen buffer, phosphatase developer (5-bromo-4-chloro-3-indoxylphosphate, nitroblue tetrazolium) and human standard for Lp(a) isoforms. The latter contained Determinants of Lp(a) levels AO Akanji et al ®ve known Lp(a) isoforms ± F, S1, S2, S3, S4 ± according to Utermann's nomenclature 17 with respective kringle IV repeat numbers of 14, 19, 23, 27 and 35, and was always included in duplicate in each run. With this commercially available kit, it was possible to speci®cally and reproducibly identify ®ve isoforms. The sample was classi®ed as a`null' phenotype when no isoform was demonstrable. Some American workers have reported on the demonstration of up to 34 isoforms for apo(a) using methods similar to the one we have used here. 18 However, apo(a) isoform nomenclature and determination remains essentially unstandardized. Furthermore, there are no commercially available controls with greater than ®ve isoforms, to our knowledge. We therefore decided to use the commercially available, easily veri®able IMMUNO AG Lp(a) phenotyping kit, with standardized, widely acceptable and published isoform numbers and nomenclature. 17, 20 
Data analysis
The generated data were analysed in relation to gender, body mass and WHR. All subjects (male and female) with BMI b 25.0 kgam 2 were considered overweight. 21 Men with WHR b 0.95 and women with WHR b 0.80 were considered to have central obesity. 22 The measure of insulin sensitivity used was the ratio of the serum insulin concentrations (mUal) to the glucose level (mmolal) and was called the insulin:glucose ratio (IGR, mUammol). 23 Subjects with Lp(a) levels greater than the 75th percentile for the population studied were considered to have elevated values, for comparison purposes (Table 3) . Results are expressed as meansAE s.d., medians and ranges as appropriate to the distribution of the data. Between group comparisons for the different parameters (age, BMI, WHR, glucose, uric acid, HDL, LDL, TC, TG, Lp(a), insulin and IGR) were performed by MannWhitney U tests. The statistical relationships between these parameters and other variables were sought using Spearman's rank correlation coef®cients and multiple regression analyses. These statistical tests were performed by computer, using the Statistical Package for the Social Sciences (SPSS). 24 The level of statistical signi®cance was P`0.05.
Results
The distribution of Lp(a) concentrations in 177 apparently healthy Kuwaiti subjects (72 male, 105 female) was positively skewed ( Figure 1 ) with a median value of 153 mgal (range 0 ± 1086). Men (median 117 mgal, range 0 ± 779) had slightly lower values than women (195, 0 ± 1086), (P 0.069). Table 1 shows the demographic, anthropometric and biochemical characteristics of the subjects as a whole, and according to gender. This table also indicates the values obtained when the data were reanalysed with the study subjects (men and women together) subdivided on the basis of BMI into normal weight (BMI`25 kgam 2 ) and overweight (BMI b 25 kgam 2 ) The men and women did not differ in age and BMI but the men had greater WHR and BP (mean, systolic, diastolic) (all P`0.001). Serum urate, glucose, TG (all P`0.001) and apo B (P`0.05) were greater in the men, although the women had higher HDL and apo A-1 concentrations, P`0.001. The levels of TC, LDL, insulin and the IGR did not differ between the sexes. As expected, the overweight subjects were older, and had greater WHR and BP (systolic, diastolic) (all P`0.001). In addition, the overweight group had a worse lipoprotein pro®le (greater TC, TG, LDL, apo B and lower HDL and apo A-1), higher glucose, urate and Lp(a) levels (P`0.01) and a greater tendency to insulin resistance with higher insulin and IGR levels (all P`0.001).
When data for the whole group were reanalysed according to gender and WHR (normal WHR`0.80 women,`0.95 for men; high WHR b 0.80 for women, b 0.95 for men) (Table 2 ), a similar pattern was observed in that the centrally obese (high WHR) tended to be older and fatter, with a tendency to greater BP, worse lipoprotein pro®le, higher glucose concentrations, and insulin resistance as indicated by higher insulin and IGR concentrations. Lp(a), HDL and apo A-1 concentrations were not in¯uenced by changes in WHR. This in¯uence of WHR on biochemical and anthropometric variables, however, differed somewhat between the men and the women. Men with central obesity had higher urate, TC, TG and LDL concentrations than those with normal WHR (P`0.05) but insulin and IGR were not in¯uenced by WHR. In women, however, the differences were more impressive, generally re¯ecting the observations for the whole group. Table 3 shows the values obtained in the subjects divided into Group A: normo-Lp(a)-emic (0 ± 75th percentile) and Group B: hyper-Lp(a)-emic ( b 75th percentile). The latter group was slightly older and fatter (both P`0.01), and also had higher TC and LDL concentrations. The other measured parameters did not differ signi®cantly between the two groups. Determinants of Lp(a) levels AO Akanji et al BMI body mass index; WHR waist:hip ratio; SBP systolic blood pressure mmHg; DBP diastolic blood pressure mmHg; TC total cholesterol; TG triglycerides; HDL high density lipoproteins; LDL low density lipoproteins; ap0 apolipoproteins; IGR insulin:glucose ratio. *P`0.001 for difference between normal and high WHR for group (male, female, all). **P`0.05 for difference between normal and high WHR for group (male, female, all).
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Correlations
In all subjects, there were signi®cant positive correlations between Lp(a) and BMI (r 0.232, P`0.005), TC (r 0.173, P 0.02), LDL (r 0.198, P`0.01) and apo B (r 0.198, P 0.05), but not with insulin. These relationships differed somewhat between men and women while Lp(a) correlated signi®cantly only with glucose in men (r 0.278, P 0.02), there were signi®cant relationships with age (r 0.196, P`0.05), BMI (r 303, P`0.005), diastolic BP (r 0.221, P 0.02), TC (r 0.196, P`0.05) and LDL (r 0.262, P`0.01) in the women. On multiple regression analyses, the independent determinants of Lp(a) were BMI (standardized beta coef®cient 0.188, P 0.017) and LDL (standardized beta coef®cient 0.155, P 0.048), both contributing about 7.8% to the Lp(a) concentration as indicated by the following equation:
These correlations were not signi®cantly qualitatively or quantitatively affected when the LDL concentrations were corrected for their Lp(a) content according to the formula: corrected LDL LDL À 0X3 Â Lpa 25 X
Apo(a) phenotypes
Of the 171 subjects studied, 114 (67%) and 51 (30%) had single and double-banded phenotypes respectively. Six (3%) had no band, had the lowest median Lp(a) concentration (20 mgal) and thus constituted the null phenotype. Five isoforms were identi®ed, corresponding to speci®c numbers of kringle IV repeats as follows ( . Isoforms F migrates faster than and S1 ± S4 slower than apo B 100. There was therefore no simple relationship between the apo (a) phenotype and the Lp(a) concentration ± except that the Lp(a) concentration was greatest in the isoform with the lowest kringle IV repeat number and fastest electrophoretic migration. Lp(a) concentrations were essentially similar in the other isoforms irrespective of kringle IV repeat numbers and electrophoretic mobility speed.
Discussion
Blood concentrations of Lp(a) are believed to be determined mainly by the concentration of its major apolipoprotein constituent, apo(a), which is polymorphic due to varying numbers of kringles in its lysine binding domain. 26 Apo (a) polymorphism is essentially genetically determined, and affects the total mass of the Lp(a) protein and its density. 26 An inverse correlation of the serum Lp(a) concentrations with the molecular weight of the apo(a) isoform and with the size of the corresponding apo(a) gene 17, 26 has indeed been demonstrated in Caucasian subjects in whom it has also been estimated that between 41 and 90% of the serum concentration is determined by the apo(a) polymorphism. 25 ± 27 This correlation, and the latter quoted percentage, is inconsistent in all populations, being as low as 19% in Sudanese blacks, 26 and it has not been described, to our knowledge, in an Arab population. BMI body mass index; WHR waist:hip ratio; SBP systolic blood pressure mmHg; DBP diastolic blood pressure mmHg; TC total cholesterol; TG triglycerides; HDL high density lipoproteins; LDL low density lipoproteins; ap0 apolipoproteins; IGR insulin:glucose ratio. *P`0.001 for difference between groups (Lp(a); insulin). **P`0.05 for difference between groups (Lp(a); insulin). 
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Similarly, the determinant of the rest of the serum Lp(a) concentration, which is highly variable (from 10 to 60%), depending on population and study, 25, 27 , is not clear. The suggestion from many other studies in different populations 2,3,7,8,11,13,14,25 ± 30 is that as yet uncharacterized, but speci®c, metabolic factors may be involved. In earlier studies on hyperlipidaemic subjects in the same population, we had shown that Lp(a) concentrations were in¯uenced by hyperlipidaemia and its phenotype, in that levels were higher with hypercholesterolaemia and lower with hypertriglyceridaemia. 15 We also established consistent positive correlations between levels of Lp(a) and TC, LDL and apo B in these subjects. These observations were con®rmed in another study in Nigerians. 25 In this current study, we have extended our earlier observations to investigate in detail, the possible interactions between the described metabolic factors and a genetic in¯uence (as indicated by apo(a) polymorphisms) on Lp(a) levels in a healthy, normolipidaemic Arab population.
Lp(a) and anthropometric, demographic and biochemical parameters
The mean serum Lp(a) concentrations in our study population was essentially similar to observations in Europeans, American whites and some Asian populations. 26 The distribution was also positively skewed, similar to the distributions in Caucasians, Chinese and some Hispanic populations. 26 These levels are lower than reported values in native Africans and African Americans, in whom the distribution is also different, being more bell-shaped with a tendency to higher values. 18, 25, 28, 31 There was, however, a tendency towards higher Lp(a) values in the women we studied (P 0.069), as in Koreans 20 and Nigerians. 25 In our women, there was also a positive correlation with age raising the possibility of the in¯uence of menopause, as previously described. 29 Indeed, ®ve of the subjects were post-menopausal, and their median Lp(a) level of 315 mgal was higher than the median for the whole group of women (195 mgal) in keeping with the report by Heinrich et al 29 of increased Lp(a) concentrations in association with menopause. It could be speculated that these menopause-related differences are due to differences in oestrogen levels, 9 though serum oestrogen concentrations were not speci®cally evaluated in this study. None of our post-menopausal women was, however, on hormone replacement therapy.
Bivariate correlations between Lp(a) and anthropometric variables or BP were more impressive in the women than in the men. While Lp(a) correlated signi®cantly with BMI in all the subjects, it also correlated with BMI and diastolic and mean BP in women, but not in men. In relation to the biochemical variables, Lp(a) correlated signi®cantly with TC, LDL and apo B in the subjects grouped as a whole, and in the women considered separately. These positive correlations were not seen in the men, in whom Lp(a) correlated only with glucose levels. These relationships have been described in our previous report, 15 and have also been reported in a Nigerian population. 25 In keeping with other published reports, 8 there were no consistent positive correlations between Lp(a) and either insulin or the insulin:glucose ratio, with the implication that elevated Lp(a) concentrations probably are not important in the development of insulin resistance which is another independent risk factor for CHD risk in some populations. 32 ± 35 In many populations, a serum Lp(a) concentration b 300 mgal is considered indicative of increased atherogenic risk. 26, 36, 37 However, levels of Lp(a) are racially and genetically determined, and it is probably not appropriate to use the same Lp(a) cut-off point to assign CHD risk in all populations. We have therefore used the 75th percentile of values obtained in our study population to indicate hyper-Lp(a)-aemia and possibly increased risk. 25% of our patients will be so classi®ed, as de®ned (Table 3 ). This group was older and had greater TC and LDL levels than the normoLp(a)-aemic group, in con®rmation of the observations on bivariate correlations described in the next section.
On multivariate analysis, only LDL and BMI remained as independent correlates of serum Lp(a) levels. The relationship with LDL persisted and was little changed after correcting the LDL concentrations for its Lp(a) content, and is not surprising, since Lp(a) is structurally related to LDL cholesterol. 10, 11 The link with BMI, although relatively weak (with LDL, 8.0%, on multiple regression analysis) offers at least one avenue for non-pharmacological reduction of elevated Lp(a) levels by the encouragement of healthy diet, physical activity and similar lifestyle changes in the obese. 9 
Apo(a) polymorphism
There is a relatively high frequency (67%) of the single-banded phenotype in the Kuwaiti population The proportions of individuals with single-banded phenotypes were 53% in Koreans, 20 89% in Austrian plasma donors 17 and 14 ± 24% in different groups of black and white Americans, 18, 19, 31 although it is believed that this percentage could possibly decrease with improved sensitivity and resolution of the SDSaagarose gel electrophoresisaimmunoblotting technique. 18 Nonetheless, as previously reported, a single banded phenotype could re¯ect: (1) homozygosity for the speci®c allele; (2) heterozygosity for the null allele; and, (3) heterozygous allele with almost the same kringle numbers that could not be separated by our method. The speci®c cause can only be determined by use of better de®nition SDSaagarose gel electrophoresis or otherwise by further detailed DNA analysis. The signi®cance of the frequency of single vs double banded phenotypes remains unclear, however. The frequency of homozygous apo (a) allele Determinants of Lp(a) levels AO Akanji et al is about 5% in Chinese, 3% in Caucasians and about 5% in African Americans. 38 Further studies are underway to con®rm the frequency of the single-banded phenotype in our population and investigate its basis.
There was no simple relationship between the number of kringle IV repeats and plasma Lp(a) concentrations in our study population. The only consistent observation was that Lp(a) concentrations were highest in isoform F and probably lowest in S4 and the null allele (Table 4) . The intermediate isoforms, S1, S2 and S3 had essentially similar Lp(a) concentrations. These observations are at some variance with reports elsewhere, where an inverse correlation between the number of kringle IV repeats and Lp(a) concentrations has been described. 20, 26 It could be a racial variation. However, it is still possible to postulate from our data that subjects with the rapidly migrating, low molecular weight (LMW) phenotype F with a relatively smaller number of kringle IV repeats would have much higher serum Lp(a) concentrations and thus a greater CHD risk than those with the more slowly migrating, relatively high molecular weight (HMW) phenotype such as S4. 17 Indeed, 33% of our subjects had LMW phenotypes (F, Sl, S2) and 67% the HMW forms (S3, S4); this is similar to the pattern in Caucasians (70% HMW) 30 but lower than the 95% of HMW observed in Koreans. 20 The F phenotype, considered rare in Caucasians 17 was also uncommon in Koreans (1%) 26 and in our population (3%). About 4% of our subjects had the`null' phenotype. This is unlikely to be due to experimental error, as these individuals also had the lowest Lp(a) concentrations. Furthermore, in Koreans, a not too dissimilar proportion (2%) had the`null' phenotype, using the same immunoblotting methodology that we have used here. 20 Additionally, the expected frequency of the`null' phenotype in black and white Americans is 1.0 ± 6.7% (similar to ours), even with a sensitive technique that identi®es up to 34 isoforms. 31 
Conclusion
These results suggest that: (1) mean values of serum Lp(a) and its distribution in the Kuwaiti Arab population are similar to patterns in Caucasians and certain Asian groups but lower than the reported values in some African and African ± American populations; (2) about a third of the population had the rapidly migrating apo(a) phenotypes (with relatively high serum Lp(a) concentrations) and the remaining twothirds have the slower migrating forms (associated with relatively lower serum Lp(a) concentrations; and (3) important metabolic correlates of serum Lp(a) are the BMI and serum LDL concentrations, offering a focus for possible attempts at reduction of high circulating levels. The relationship between Lp(a) and LDL concentrations had previously been described in our hyperlipidaemic population. There was no signi®cant relationship between Lp(a) and insulin andaor insulin sensitivity.
